Recital 4, Regulation (EU) 2024/858

In forcesince 14 Mar 2024

On 25 June 2021, the SCCS adopted an Opinion [SCCS (Scientific Committee on Consumer Safety), Opinion on Gold (nano), Colloidal Gold (nano), Gold Thioethylamino Hyaluronic Acid (nano) and Acetyl heptapeptide-9 Colloidal gold (nano), final version of 24-25 June 2021, SCCS/1629/2021.] on Gold (nano), Colloidal Gold (nano) (CAS No 7440-57-5), Gold Thioethylamino Hyaluronic Acid (nano) (CAS No 1360157-34-1) and Acetyl heptapeptide-9 Colloidal gold (nano) (CAS No. not reported)and an Opinion [SCCS (Scientific Committee on Consumer Safety), Opinion on Platinum (nano), Colloidal Platinum (nano) and Acetyl tetrapeptide-17 Colloidal Platinum (nano), final version of 24-25 June 2021, SCCS/1630/21.] on Platinum (nano), Colloidal Platinum (nano) (CAS No 7440-06-4) and Acetyl tetrapeptide-17 Colloidal Platinum (nano) (CAS No. not reported). In both opinions, the SCCS concluded that it is not possible to carry out a safety assessment due to the limited or missing essential information. However, based on the collective consideration of the physicochemical, toxicological and exposure aspects, it also concluded that the use of such nanomaterials in cosmetic products can pose a health risk to the consumer.